Skip to the story
All stories

US prescription drug prices fall 3.1% in year to July, steepest drop since 1963

Trump administration and Biden-era Medicare negotiations both credited by different outlets for the decline

AI-assisted coverage comparison, editor-supervised · How this was made

Published
Inside Brooklyn’s seedy Penn Track sex market where pimps, murder and human trafficking are part of daily life

What this story says

  • Prescription drug prices in the US fell 3.1% in the year to July 2026, the steepest annual decline since 1963, according to federal inflation data.
  • The White House credited Trump administration policies, including the Most Favored Nation rule and the TrumpRx platform, for the drop.
  • Independent experts, as reported by Axios, attributed the decline to Medicare drug price negotiations under the Inflation Reduction Act, a Biden-era policy.
  • Pfizer committed to discounts of up to 85% on several drugs as part of the TrumpRx platform, reducing prices for treatments including Duavee and Tobias.

Who covered it

Left 18%(2)Centre 18%(2)Right 64%(7)

Percentages are shares of the 11 outlets carrying a published leaning rating. 4 of the 15 outlets we know ran this story carry no rating and are not counted in them. Coverage measured .

Trust

55/100

Craft

55/100

Hype

55/100

15 sources · methodology

Thin on the left so far

Only 2 of the 11 outlets with a published leaning rating that ran this story are rated left.

This story is still being watched, so it is a count and not yet a finding. Coverage keeps arriving for hours after an event, and a side that has published nothing this morning may publish by tonight. If it is still true when we stop checking, we will say so plainly.

Prescription drug prices in the United States fell 3.1% over the 12 months ending in July 2026, the largest annual decline recorded since 1963. The drop was confirmed in federal inflation data released in August. The White House issued a statement on 17 August attributing the decline to policies implemented during the Trump administration, including the Most Favored Nation rule and the TrumpRx platform, which lists discounts for uninsured patients.

Pfizer announced discounts of up to 85% on several drugs through the TrumpRx platform. The menopause treatment Duavee was reduced to $30 per prescription, while the overactive bladder drug Tobias fell to $42. The eczema ointment Eucrisia was discounted by 80%, to $162 per tube. The migraine drug Zavzpret and rheumatoid arthritis treatment Xeljanz also saw price cuts of 50% and 40%, respectively.

Axios reported that independent experts credited Medicare drug price negotiations under the Inflation Reduction Act, a policy introduced during the Biden administration, for contributing to the decline. The White House spokesman Kush Desai dismissed this claim as "idiotic and unfounded," according to the New York Post.

Disagreement over what caused the price drop

Outlets disagreed on which administration’s policies were responsible for the decline in prescription drug prices. The New York Post reported that the White House attributed the drop to Trump administration policies, including the Most Favored Nation rule and the TrumpRx platform. Der Standard and Axios, however, reported that independent experts credited Medicare drug price negotiations under the Inflation Reduction Act, a Biden-era policy, for the decline.

What the coverage left out

None of the right-rated digests mentioned the role of Medicare drug price negotiations under the Inflation Reduction Act in the price decline. The New York Post’s full report dismissed the claim as "idiotic and unfounded" but did not include the perspective of independent experts who supported it. None of the left-rated reports included the White House’s dismissal of the Biden-era policy’s impact.

Still developing. We have re-checked which outlets are covering this 4 times, most recently on 18 Aug 2026, 09:00, and will add the sides that appear.

How other outlets pictured it

Which photograph to run is each newsroom’s own choice. The leaning beside a name is that outlet’s published rating, not a claim that the pictures divide along it. Every picture is shown from the outlet’s own server and links to the article it ran in.

Bevor es für Trump in den Flieger ging, wollte er den Medien auf der Joint Base Andrews in Maryland noch etwas mitgeben.
der Standard ATLeft

How each side covered it

Our own reading of the reporting listed below, written from the outlets’ articles rather than quoted from them. The reasoning is set out on our methodology page.

Left

2 rated outlets

  • The two left-rated reports led on the role of Biden-era policies in the price decline. Der Standard’s full report stated that while Trump claimed credit for the drop, "experts see it as a long-term achievement of Donald Trump’s predecessor." The outlet quoted unnamed experts who attributed the decline to policies introduced during the Biden administration. Axios’s digest reported that independent experts credited Medicare drug price negotiations under the Inflation Reduction Act for the decline.

Centre

2 rated outlets

  • The centre-rated report, from Political Wire, led on the scale of the price decline. Its digest stated, "America is experiencing its biggest prescription drug price deflation in generations," citing Axios. The report framed the decline as part of a "major Washington push to lower drug costs" but did not attribute the cause to either administration.

Right

7 rated outlets

  • The seven right-rated digests all led on the Trump administration’s role in the price decline. The New York Post’s full report quoted the White House stating that Trump had "delivered" on his promise to slash prescription drug prices. The report described the decline as the result of Trump’s "pressure on drug companies," including threats of tariffs and the establishment of the TrumpRx platform. It quoted the White House email: "New data confirms prescription drug prices just recorded their largest annual decline in more than 60 years."
  • The National Pulse’s digest reported a 3.9% decline in prescription drug prices since Trump took office, though this figure was not corroborated by other outlets. Real News Now and the NRCC both credited the Trump administration’s policies, including the Most Favored Nation rule and the TrumpRx platform, for the decline. RedState’s digest noted that Trump celebrated the drop while the media "feverishly works to credit Biden."

Read it at the source

15 outlets, grouped by the leaning a published rating gives them. Every headline links to the original; an underlined outlet name opens our profile of that publisher.

Left

2

Centre

2

Right

7

Not rated

4

Questions about this coverage

How did the left and right cover US prescription drug prices fall 3.1% in year to July, steepest drop…?
Of the 11 outlets on this story carrying a published leaning rating, 18% are rated left, 18% are rated centre, 64% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 15. The sections above set out what each side emphasised, in its own terms.
Is US prescription drug prices fall 3.1% in year to July, steepest drop… left or right?
Too few of the outlets on this story carry a published leaning rating to say. 11 of them do, and this site does not characterise a field under 12: at that size one newsroom filing moves the share by ten points. The percentages above are the count as it stands.
Is the coverage of US prescription drug prices fall 3.1% in year to July, steepest drop… biased?
US prescription drug prices fall 3.1% in year to July, steepest drop since 1963 is one event reported by 15 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.
Which side is not reporting US prescription drug prices fall 3.1% in year to July, steepest drop…?
When we first saw this story, outlets rated left had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.
Which outlets covered US prescription drug prices fall 3.1% in year to July, steepest drop…?
15 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.
What caused the 3.1% drop in US prescription drug prices?
The White House attributed the decline to Trump administration policies, including the Most Favored Nation rule and the TrumpRx platform. Independent experts, as reported by Axios, credited Medicare drug price negotiations under the Inflation Reduction Act, a Biden-era policy. Outlets disagreed on which administration’s policies were responsible.
How much did prescription drug prices fall in the US?
Prescription drug prices in the US fell 3.1% over the 12 months ending in July 2026, the steepest annual decline since 1963. The drop was recorded in federal inflation data and confirmed by multiple outlets, including the New York Post and Axios.
Which drugs saw the largest price cuts under the TrumpRx platform?
Pfizer committed to discounts of up to 85% on several drugs through the TrumpRx platform. The menopause treatment Duavee was reduced to $30, the overactive bladder drug Tobias to $42, and the eczema ointment Eucrisia to $162 per tube. The migraine drug Zavzpret and rheumatoid arthritis treatment Xeljanz also saw price cuts.

How did this read?

About the coverage, not about the story. We do not ask whether you agree with what happened — we have no honest use for that answer.

US drug prices fall 3.1% in year to July 2026 | MediaBias News